Update on contraception: Benefits and risks of the new formulations

  • Cleveland Clinic Journal of Medicine
  • August 2003,
  • 70
  • (8)
  • 681-695;

ABSTRACT

Several new contraceptives have become available to women in recent years. These new agents include ultra-low-dose oral contraceptives as well as injectable, vaginal, and patch formulations. We review these, with emphasis on the Yasmin pill (which contains a new progestin), the Lunelle once-a-month injection, the Ortho Evra patch, the NuvaRing vaginal ring, the Mirena intrauterine device, and emergency contraceptive kits. Patient education regarding these options is essential for patient compliance and satisfaction.

Loading
  • Print
  • Download PDF
  • Article Alerts
  • Email Article
  • Citation Tools
  • Share

Jump to section